Mechanisms of tax regulation of human T cell leukemia virus type I gene expression

Journal of Biomedical Science

Volumn 2, Issue 1, 1995, Pages 17-29

  Franklin, Audrey A ^a   Nyborg, Jennifer K ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Activating transcription factor; Basic helix loop helix; Basic leucine zipper proteins; cAMP response element binding protein; NF B; Trans activation

Indexed keywords

BASIC PROTEIN; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR;

GENE EXPRESSION; GENOME; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; ONCOGENE; PRIORITY JOURNAL; REVIEW;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0028821369     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02257921     Document Type: Review

References (242)

1. Phosphorylation of the Rex protein of human T-cell leukemia virus type I
2. Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at position 282–284 near the conserved DNA-binding domain of CREB
3. Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: Insights into the mechanism of Rex and Rev action
4. Transactivation of Krox-20 and Krox-24 promoters by the HTLV-I Tax protein through common regulatory elements
5. Four regulatory elements in the human c- fos promoter mediate trans-activation by HTLV-1 Tax protein
6. Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns
7. Quantitative studies of the effect of HTLV-I Tax protein on CREB proteins-DNA binding
8. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eucaryotic transcription factors
9. HTLV-I Tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene
10. Functional analysis of human T-cell leukemia virus type I rex-response element: Direct RNA binding of Rex protein correlates with in vivo activity
11. Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis
12. Direct interaction of CREB protein with 21 base pair Tax-responsive elements of HTLV-1 LTR
13. Isolation and characterization of the Tax protein of HTLV-1
14. Binding of the HTLV-1 Tax 1 transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1
15. HTLV-I-associated myelopathy: Clinicopathologic correlation with localization of provirus to spinal cord
16. Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure
17. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma
18. The human T-cell leukemia/lymphoma virus in the southeastern United States
19. Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element
20. The same inducible nuclear proteins regulate mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV
21. The product of the c- ets-1 protooncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-I
22. Myb proteins bind to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression
23. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat
24. Bovine leukemia virus: Molecular biology and epidemiology
25. In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes
26. Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation
27. HTLV-II transforms normal human lymphocytes
28. The x gene is essential for HTLV replication
29. Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys
30. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I
31. Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line
32. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor
33. Twenty-one base pair repeat elements influence the ability of a Ga14-Tax fusion protein to trans-activate the HTLV-1 long terminal repeat
34. Regulation of the human interleukin-2 receptor α chain promoter: Activation of a non-functional promoter by the trans-activator gene of HTLV-1
35. Human immunodeficiency virus as a prototypic complex retrovirus
36. Sequence variants of human T-lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates
37. Construction and expression of a monomeric c-jun protein that binds and activates transcription of AP-1-responsive genes
38. Coexistence of human T-lymphotropic virus type I and II among the Wayuu Indians from the Guajira region of Colombia
39. (HTLV) type II infection among high-risk individuals: Type-specific identification of HTLVs by polymerase chain reaction
40. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease
41. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I
42. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats
43. Phorbol esters modulate the phosphorylation of human T-cell leukemia virus type I Tax
44. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase
45. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of proteins with adult T-cell leukemia
46. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) and cAMP element-binding protein (CREB)
47. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I
48. Interaction of HTLV-I with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes
49. HTLV-1 tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity
50. Functional activation of the human T-cell leukemia virus type I by transacting factor
51. A transcriptional enhancer sequence of HTLV-1 is responsible for trans-activation mediated by p40x of HTLV-1
52. A unique enhancer element for the trans-activator (p40tax) of human T cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive element
53. The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation
54. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma
55. Human T cell leukemia/lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T cell lymphoma
56. Synergistic activation of the HTLV-I LTR ets-responsive region by transcription factors ets1 and Sp1
57. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis
58. Human T-cell leukemia/lymphoma virus type I (HTLV-I) expression in fresh of peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-1-associated myelopathy
59. HTLV-I Tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element
60. Sequence-specific interaction of the ETS 1 protein with the long terminal repeat of the human T-lymphotropic virus type I
61. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and ets1
62. Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus
63. Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I
64. Role of human T-cell leukemia virus type I X region proteins in immortalization of primary human lymphocytes in culture
65. Transformation to continuous growth of primary human T lymphocytes by human T cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector
66. Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression
67. Deleted HTLV-1 provirus in blood and cutaneous lesions of patients with mycosis fungoides
68. Concomitant infections with human T-cell leukemia viruses (HTLVs) and human immunodeficiency virus (HIV): Identification of HTLV-II infection in intravenous drug abusers (IVDAs)
69. Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements
70. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies
71. Mutational analysis of the HTLV-I trans-activator, Tax
72. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins
73. Mother-to-child transmission of human leukemia virus type-1
74. A transgenic mouse model for human neurofibromatosis
75. Antibodies to adult T-cell leukemia virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide sero-epidemiologic study
76. Adult T-cell leukemia: Antigen in ATL cell line and detection of antibodies to the antigen in human sera
77. Seroepidemiology of adult T-cell leukemia virus (HTLV-I/ATLV): Origin of virus carriers in Japan
78. Chronic neurodegenerative disease associated with HTLV-II infection
79. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population
80. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: Determination by sequence-specific oligonucleotide hybridization
81. Infection of human endothelial cells by human T-lymphotropic virus type I
82. Human T cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures
83. Lymphoma in macaques: Association with virus of human T-lymphotropic family
84. Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia
85. Infection of human endothelial cells by human T-cell leukemia virus type I
86. Detection of serum antibodies to adult T-cell leukemia virus in non-human primates and in people from Africa
87. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I
88. The second pX product p27x-III of HTLV-1 is required for gag gene expression
89. Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes
90. Expression of HTLV-I in serum of HTLV-I-related subjects and the early detection of overt ATL in HTLV-I carriers
91. HTLV-I rex and HIV-I rev act through similar mechanisms to relieve suppression of unspliced RNA expression
92. Human T-cell leukemia virus type-1 infection and chronic myelopathy
93. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I associated myelopathy/tropical spastic paraparesis
94. Isolation of an HTLV-I-like retrovirus from patients with tropical spastic paraparesis
95. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-1 associated neurological disease
96. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence
97. HTLV-1 trans-activator protein, Tax, is a trans-repressor of the human β-polymerase gene
98. Role of protein kinase A in Tax trans-activation of the human T-cell leukemia virus type I long terminal repeat
99. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia
100. Natural antibodies to the structural protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in the sera of leukemia patients in Japan
101. Chromosome abnormalities in adult T cell leukemia/lymphoma: A karyotype review committee report
102. Predominant recognition of human T-cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells
103. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I
104. Leukemogenesis by bovine leukemia virus: Proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences
105. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: An old infection?
106. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States
107. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases
108. Rex trans-regulation of human T-cell leukemia virus type II gene expression
109. Development of adult T cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen positive healthy adults
110. Detection of mRNA for the Tax/Rex gene of HTLV-I in fresh peripheral blood mononuclear cells of ATL patients and viral carriers, using the PCR reaction
111. Sequence variations in LTR and Env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia
112. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I
113. Specific adsorption of HTLV-1 to various target human and animal cells
114. Deregulation of interleukin-2 receptor gene expression in HTLV-I induced adult T-cell leukemia
115. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing
116. Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy
117. Infective dermatitis of Jamaican children: A marker for HTLV-I infection
118. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama
119. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans
120. Transcriptional regulation by CREB and its relatives
121. HTLV-I trans-activator induces interleukin-2 receptor expression through an NF-κB-like factor
122. Geographic distribution of HTLV-I and identification of a new high-risk population
123. Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element
124. Endemic human T cell lymphotropic virus II infection among isolated Brazilian Amerindians
125. HTLV-I-associated B-cell CLL: Indirect role for retrovirus in leukemogenesis
126. Indirect binding of human T-cell leukemia virus type I Tax1 to a responsive element in the viral long terminal repeat
127. A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat
128. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I encoded p40x and T3/Ti complex triggering
129. In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein
130. Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression
131. Natural antibodies to human T-cell leukemia/lymphoma virus in healthy Venezuelan populations
132. Efficient transformation of previously activated and dividing T lymphocytes by human T cell leukemia-lymphoma virus
133. Virus-like particles in phytohemagglutinin-stimulated lymphocyte culture with reference to bovine lymphosarcoma
134. Familial adult T-cell leukemia
135. Type C virus particles in cord T-cell lines derived by co-cultivating normal cord leukocytes and human leukemic T cells
136. Tax1 induction of the HTLV-I 21 bp enhancer requires cooperation between two cellular DNA-binding proteins
137. Tropical spastic paraparesis: A model of virus-induced cytotoxic T-cell mediated destruction?
138. HTLV-I and polyositis in Jamaica
139. Familial occurrence of HTLV-1-associated myelopathy
140. The epidemiology of HTLV-1 infection
141. Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/HAM. Comparison to other HTLV-I isolates
142. Modelling the risk of ATLL in persons infected with HTLV-1
143. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis
144. Differential activation of the 21 base pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP
145. The tat gene of human T-lymphotropic virus type I induces mesenchymal tumors in transgenic mice
146. Multistep regulation of enhancer activity of the 21 base-pair element of human T-cell leukemia virus type I
147. Chronic inflammatory arthropathy associated with HTLV-1
148. Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA
149. Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I
150. Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type 1: Implications for viral gene expression
151. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region: Purification of cellular proteins that bind the 21-base pair repeat elements
152. Interaction of host cell proteins with the human T-cell leukemia virus type I transcriptional control region
153. Evidence for phosphorylation of trans-activator p40x of human T-cell leukemia virus type I produced in insect cells with a Baculovirus expression vector
154. HTLV-I associated lymphadenopathy
155. Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA
156. A retrospective study of transmission of adult T-cell leukemia virus by blood transfusion: Seroconversion in recipients
157. Adult T-cell leukemia virus, blood donors and transfusion: Experience in Japan
158. HTLV-1 associated myelopathy: A new clinical entity
159. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax
160. Activated HTLV-I specific cytotoxic T cells are found in healthy seropositives as well as patients with tropical spastic paraparesis
161. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously
162. Cis-Acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer
163. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
164. Isolation of a new type-C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia and evidence for virus nucleic acids and antigens in fresh leukemic cells
165. Isolation and transmission of human retrovirus (human T cell leukemia virus)
166. Protein kinase A-dependent binding of a nuclear factor to the 21-base pair repeat of the human T-cell leukemia virus type I long terminal repeat
167. Response of the human T-cell leukemia virus type I long terminal repeat to cyclic AMP
168. The human T lymphotropic virus I tax gene can cooperate with the ras oncogene to induce neoplastic transformation in cells
169. Molecular cloning of human T-cell lymphotropic virus type-I like proviral genome from the peripheral lymphocyte DNA of a patient with chronic neurologic disorders
170. Seroepidemiology of human T cell lymphotropic virus in the Republic of Panama
171. The nucleotide sequence of the env gene and post- env region of bovine leukemia virus
172. In vivo cellular tropism of human T-cell leukemia virus type 1
173. Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia
174. Prevalence of anti-bodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region
175. The open reading frame I (ORF I/ORF II) part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27rex, or envelope expression
176. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat
177. Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia
178. Integrated HTLV-II genome in CD8+ T-cells from a patient with ‘atypical’ hairy-cell leukemia: evidence for distinct T-and B-cell lymphoproliferative disorders
179. A second isolate of HTLV-II associated with atypical hairy-cell leukemia
180. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product
181. Complete nucleotide sequence of the genome of bovine leukemia virus: Its evolutionary relationship to other retroviruses
182. Sequence and phylogenetic analyses of a new STLV-1 from a naturally infected Tantalus monkey from Central America
183. Human T-cell leukemia virus (HTLV-I) antibodies in Africa
184. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells
185. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
186. Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family
187. Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I
188. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator
189. HTLV-I Tax is a zinc-binding protein: role of Zinc in Tax structure and function
190. Mutational analysis of human T-cell leukemia virus type I Tax. Regions necessary for function determined with 47 mutant proteins
191. Nucleotide sequence of the 3′ region of an infectious human T-cell leukemia virus type II genome
192. Requirement of multiple copies of a 21-nucleotide sequence in the U3 region of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription
193. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: An open reading frame for the protease gene
194. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia
195. Retrovirus from human T-cell leukemia virus type I associated myelopathy is the same strain as a prototype human T-cell leukemia virus type I
196. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator tat gene product of human T-cell leukemia virus, type I
197. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing
198. Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I
199. Studies of the putative transforming protein of the type I human T-cell leukemia virus
200. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes
201. Type I human T-cell leukemia virus Tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway
202. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus
203. Trans-acting transcriptional activation of the long terminal repeat of human T-cell lymphotropic viruses in infected cells
204. Human T-cell leukemia viruses use a receptor determined by human chromosome 17
205. Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin
206. The trans-activator Tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-response element (CRE) binding and CRE modulator proteins that bind to the 21-base pair enhancer of HTLV-I
207. The 4th nationwide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features
208. Clinical aspects of adult T-cell leukemia/lymphoma
209. Purification and characterization of multiple nuclear factors that bind to the Tax-inducible enhancer within the human T-cell leukemia virus type I long terminal repeat
210. Utilization of signal transduction pathways by the human T-cell leukemia virus type I transcriptional activator Tax
211. Oncogenic transformation by the Tax gene of human T-cell leukemia virus type I in vitro
212. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type I and cloning of cDNA's encoding its binding proteins
213. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes
214. Secondary structure of the human T-cell leukemia virus type 1 rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs
215. Two distinct regions form a functional activation domain of the HTLV-1 trans-activator Tax1
216. Isolation of cDNAs for DNA-binding proteins which specifically bind to a Tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I
217. Nucleotide sequence analysis of a provirus derived from HTLV-1 associated myelopathy (HAM)
218. Adult T-cell leukemia: clinical and hematologic features of 16 cases
219. HTLV-I Tax protein represses gene expression through the bHLH family of transcription factors
220. Close association between interleukin 2 receptor mRNA expression and human T-cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T-cell leukemia patients
221. The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA
222. T-lymphocyte alveolitis, tropical spastic paraparesis, and Sjogren's syndrome
223. HTLV x gene mutants exhibit novel transcriptional regulatory phenotypes
224. HTLV x-gene product: requirement for the env methionine initiation codon
225. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization
226. Human T-cell leukemia virus type I is a member of the African subtype of simian viruses (STLV)
227. Sequence homology of the simian retrovirus genome with human T-cell leukemia virus type I
228. Seroprevalence and epidemiological correlates of HTLV-I infection in US blood donors
229. Human T-lymphotropic retroviruses
230. A survey of human leukemias for sequences of human retroviruses
231. Cellular factors involved in transcription of Tax-mediated trans-activation directed by the TGACGT motifs in human T-cell leukemia virus type I promoter
232. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line
233. Viruses detected in HTLV-I-associated melopathy and adult T-cell leukaemia are identical on DNA blotting
234. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
235. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease
236. Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-I: All contain a leucine zipper and a basic amino acid domain
237. HTLV-II infection in Italian drug users
238. Human T-cell lymphotropic virus type I (HTLV-1) transcriptional activator, tax, enhances CREB Binding to HTLV-1 21-base-pair repeats by protein-protein interaction
239. Interaction of the human T-cell lymphotrophic virus type I (HTLV-1) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-1 enhancer
240. Transcription factors: a new family gathers at the cAMP response site